Author + information
- Mustafa Husaini, MDa,∗ (, )@husainim,
- Joshua N. Baker, MDb,
- Sharon Cresci, MDa,
- Richard Bach, MDa and
- Shane J. LaRue, MDa@ShaneRue
- aDepartment of Medicine, Cardiovascular Division, Washington University School of Medicine, St. Louis, Missouri
- bMissouri Baptist, St. Louis, Missouri
- ↵∗Address for correspondence:
Dr. Mustafa Husaini, Washington University in Saint Louis, 660 South Euclid Avenue, CB 8086, St. Louis, Missouri 63110.
Providing hemodynamic support for patients with hypertrophic cardiomyopathy and cardiogenic shock can be challenging because inotropic medications worsen intraventricular obstruction, and the effect of appropriate mechanical support remains undefined. We report a patient with hypertrophic cardiomyopathy in shock because of takotsubo cardiomyopathy requiring venoarterial extracorporeal membrane oxygenation and septal reduction for full recovery. (Level of Difficulty: Advanced.)
Dr. Bach has received institutional research funding but no personal fees from MyoKardia and Cytokinetics for conducting clinical trials. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC: Case Reports author instructions page.
- Received January 24, 2020.
- Revision received March 16, 2020.
- Accepted April 23, 2020.
- 2020 The Authors